Amylyx Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-5.94-7.55-10.85-11.78
Price/Sales ratio
N/AN/AN/AN/A
Earnings per Share (EPS)
$-1.31$-1.03$-0.72$-0.66

Historical Multiples (2019 – 2023)

2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-68.86-22.75-11.89-12.3820.08-9.65-17.32
Price/Sales ratio
715.521.56K3.66K110.552.5986.161.88K
Price/Book Value ratio
-40.23-15.29-6.917.212.285.62-11.10
Price/Cash Flow ratio
-95.47-27.80-13.97-13.6683.03-10.64-20.89
Price/Free Cash Flow ratio
-95.47-27.69-13.91-13.4792.68-10.50-20.80
Price/Earnings Growth ratio
N/A-0.11-0.12-0.12-0.160.07-0.12
Dividend Yield
N/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-734.43%-3683.69%81.75%86.53%93.31%86.53%-1800.96%
Operating Profit Margin
-950.49%-6000.76%-29013.33%-905.71%10.19%-905.71%-17507.05%
Pretax Profit Margin
-961.85%-6504.61%-30852.98%-888.89%14.25%-888.89%-18678.79%
Net Profit Margin
-1038.99%-6898%-30834.73%-892.37%12.93%-892.37%-18866.36%
Effective Tax Rate
-8.01%-6.04%0.05%-0.39%9.25%-0.39%-0.16%
Return on Assets
-460.12%-317.90%-83.20%-50.67%9.52%-50.67%-200.55%
Return On Equity
58.42%67.19%58.13%-58.24%11.36%-86.40%-0.05%
Return on Capital Employed
1035.44%-575.46%-93.73%-58.38%8.91%-58.38%-334.59%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/A8.19N/A
Quick Ratio
0.701.865.837.985.197.773.84
Cash ratio
0.681.752.881.342.071.342.11
Days of Sales Outstanding
N/AN/AN/A251.3138.38251.31125.65
Days of Inventory outstanding
N/AN/AN/A1.19K549.811.19K595.67
Operating Cycle
N/AN/AN/A1.44K588.201.25K721.32
Days of Payables Outstanding
67.3353.6230.68K763.04316.50763.0415.72K
Cash Conversion Cycle
-67.33-53.62-30.68K679.60271.69-217.98-15.45K
Debt Ratios
Debt Ratio
4.630.10N/A0.000.000.120.06
Debt Equity Ratio
-0.58-0.02N/A0.000.000.140.07
Long-term Debt to Capitalization
-1.43-0.02N/AN/AN/A0.01N/A
Total Debt to Capitalization
-1.43-0.02N/A0.000.000.010.00
Interest Coverage Ratio
N/AN/AN/AN/AN/A-46.92N/A
Cash Flow to Debt Ratio
-0.71-25.75N/A-88.175.28-28.65-14.32
Company Equity Multiplier
-0.12-0.21-0.691.141.191.14-0.45
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-7.49-56.45-262.45-8.090.03-8.09-159.45
Free Cash Flow / Operating Cash Flow Ratio
11.001.001.010.891.011.00
Cash Flow Coverage Ratio
-0.71-25.75N/A-88.175.28-28.65-14.32
Short Term Coverage Ratio
N/AN/AN/A-88.175.28-88.17-44.08
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/A